Salix Pharmaceuticals to Present at Three Investment Conferences in June
RALEIGH, NC, May 30, 2011 – Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company will present at three health care investment conferences during June 2011. Information of these conferences is provided below:
Jefferies 2011 Global Healthcare Conference
New York, NY Monday, June 6, 2011 11:00 a.m. ET
Goldman Sachs 32nd Annual Global Healthcare Conference
Los Angeles, CA Wednesday, June 8, 2011 1:40 p.m. ET
2011 Wells Fargo Securities Healthcare Conference
Boston, MA Wednesday, June, 22 1:30 p.m. ET
Interested parties can access a live audio web cast of these presentations at www.salix.com. A replay of the presentations will be available at the same location.
Salix Pharmaceuticals, Ltd., headquartered in Raleigh, North Carolina, develops and markets prescription pharmaceutical products for the treatment of gastrointestinal diseases. Salix's strategy is to in–license late–stage or marketed proprietary therapeutic drugs, complete any required development and regulatory submission of these products, and market them through the Company's gastroenterology specialty sales and marketing team.
Salix trades on the NASDAQ Global Select Market under the ticker symbol "SLXP".
For more information, please visit our Website at www.salix.com or contact the Company at 919–862–1000. Follow us on Twitter (@SalixPharma) and Facebook (www.facebook.com/SalixPharma ). Information on our web site is not incorporated in our SEC filings.